Graphite Bio, Inc. (GRPH) has a market capitalization of $185.19M and trades at $3.18. The 52-week range is 3.05-29.82.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.1, Earnings Per Share (EPS) of $-2.85, annual revenue of $19.09M.
The stock has a beta of 0.20, a last dividend of $2.0600, operates in the Healthcare sector.
